Literature DB >> 9061223

The effect of anti-IL-4 monoclonal antibody, rapamycin and interferon-gamma on airway hyperreactivity to acetylcholine in mice.

H Nagai1, Y Maeda, H Tanaka.   

Abstract

BACKGROUND: The role of IgE in airway hyperreactivity is obscure.
OBJECTIVE: In order to clarify the role of IgE in airway hyperreactivity, we investigated the effect of anti-IL-4 monoclonal antibody, rapamycin and interferon-gamma on the antigen-induced IgE response, airway eosinophilia and hyperreactivity in mice.
METHODS: Mice were immunized with an antigen (ovalbumin; OA) at intervals of 12 days. OA was inhaled 10 days after the secondary immunization. Twenty-four hours after the last inhalation, airway reactivity to acetylcholine was measured and bronchoalveolar lavage fluid (BALF) was obtained.
RESULTS: Three inhalations of antigen caused an increase in the number of eosinophils in bronchoalveolar lavage fluid (BALF) and in airway hyperreactivity to acetylcholine with a significant elevation of serum IgE level. Anti-IL-4 at a dose of 1000 micrograms/animal and rapamycin at doses between 0.1 and 1 mg/kg inhibited the IgE production, but did not affect the airway eosinophilia or hyperreactivity to acetylcholine. In contrast, IFN-gamma clearly inhibited the antigen-induced airway eosinophilia and hyperreactivity, but did not affect the IgE antibody production.
CONCLUSION: These results suggest that the inhibition of IgE production does not suppress the onset of airway hyperreactivity and eosinophilia in mice, and that IFN-gamma inhibits the antigen-induced airway hyperreactivity, probably due to the inhibition of airway eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9061223

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

1.  Inhibitory effects of endogenous and exogenous interferon-gamma on bronchial hyperresponsiveness, allergic inflammation and T-helper 2 cytokines in Brown-Norway rats.

Authors:  T J Huang; P A MacAry; T Wilke; D M Kemeny; K F Chung
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

2.  Disruption of antigen-induced airway inflammation and airway hyper-responsiveness in low affinity neurotrophin receptor p75 gene deficient mice.

Authors:  S Tokuoka; Y Takahashi; T Masuda; H Tanaka; S Furukawa; H Nagai
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Interferon-gamma- and interleukin-4-targeted gene therapy for atopic allergic disease.

Authors:  K W Kang; T S Kim; K M Kim
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

4.  Rapamycin attenuates airway hyperreactivity, goblet cells, and IgE in experimental allergic asthma.

Authors:  Elizabeth M Mushaben; Elizabeth L Kramer; Eric B Brandt; Gurjit K Khurana Hershey; Timothy D Le Cras
Journal:  J Immunol       Date:  2011-10-21       Impact factor: 5.422

5.  Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma.

Authors:  Masato Komai; Hiroyuki Tanaka; Taisei Masuda; Koichi Nagao; Masayuki Ishizaki; Masatsugu Sawada; Hiroichi Nagai
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  Inhibition of protein kinase C delta attenuates allergic airway inflammation through suppression of PI3K/Akt/mTOR/HIF-1 alpha/VEGF pathway.

Authors:  Yun Ho Choi; Guang Yu Jin; Liang Chang Li; Guang Hai Yan
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.